Ritonavir Active Not Recruiting Phase 3 Trials for Human Immunodeficiency Virus Type 1 (HIV-1) Infection Treatment

Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02397096Safety and Efficacy of a Switch to MK-1439A in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024)
NCT01281813TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company Sponsored Studies With DRV